0001437749-23-004241.txt : 20230222 0001437749-23-004241.hdr.sgml : 20230222 20230222183505 ACCESSION NUMBER: 0001437749-23-004241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230218 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berger Mark Stanley CENTRAL INDEX KEY: 0001700283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38244 FILM NUMBER: 23655199 MAIL ADDRESS: STREET 1: 140 RIVERSIDE DRIVE STREET 2: APT. 9K CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genprex, Inc. CENTRAL INDEX KEY: 0001595248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900772347 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 BUSINESS PHONE: 512-537-7997 MAIL ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 4 1 rdgdoc.xml FORM 4 X0306 4 2023-02-18 0001595248 Genprex, Inc. GNPX 0001700283 Berger Mark Stanley 3300 BEE CAVE ROAD #650-227 AUSTIN TX 78746 1 Chief Medical Officer Common Stock 2023-02-18 4 A 0 245000 0 A 245000 D This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. /s/ Catherine Vaczy as Attorney-in-Fact for Mark Berger 2023-02-22